Thomas D. Reed, Chief Science Officer at INTREXON CORP (XON), bought 640 shares at $15.60 ($10K) on 2014-05-13, disclosed to the SEC on 2014-05-13.
Open-market purchase of $10k XON by Chief Science Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| XON | SELL | 2020-01-03 | $20K | — | Filing → |
| XON | SELL | 2019-10-02 | $20K | — | Filing → |
| XON | SELL | 2019-07-02 | $27K | — | Filing → |